Current Genomics
Current Genomics is a peer-reviewed journal devoted to genome science. Founded in 2000 by Bentham Science Publishers, it has been published since 2026 by KeAi, the brand run jointly by Elsevier and China Science Publishing, and has moved to full open access, issuing five to seven numbers a year in recent volumes. The journal positions itself on the latest developments in genomics, with equal attention to systems-biology and computational approaches to human health and disease.《当代基因组学》（''Current Genomics'''）是一份聚焦基因组科学的同行评审学术期刊，二〇〇〇年由本特纳姆科学出版社创办，二〇二六年起改由爱思唯尔与科学出版合资的 KeAi 品牌出版并转为完全开放获取，近年每年出刊五至七期。该刊以基因组学最新进展为核心定位，兼顾系统生物学与计算生物学方法在人类健康与疾病研究中的应用。
Scope
Current Genomics sets out to keep its readers abreast of the most important developments in genome science and related fields, welcoming both fundamental mechanism studies and work oriented towards clinical genomics and precision medicine, while on the methodological side it explicitly covers systems biology, modelling and machine learning. Its principal subject areas include:Current Genomics 的取稿立场是「让读者跟上基因组学及其相关领域最重要进展」，既收基础机制研究，也收面向临床基因组学与精准医学的应用工作，方法学层面则明确覆盖系统生物学、建模与机器学习方向。收文范围覆盖的主要方向包括：
- Systems biology and modelling: systems biology, systems modelling, network inference and quantitative biology, emphasising holistic approaches to how genomes are organised and behave.系统生物学与建模： 系统生物学、系统建模、网络推断与定量生物学，强调以整体视角理解基因组的组织与行为。
- Computational and informatics methods: bioinformatics, computational biology and machine learning as applied to the analysis of genomic data, including algorithm assessment and data integration.计算与信息学方法： 生物信息学、计算生物学与机器学习在基因组数据解析中的应用，包括算法评估与数据整合。
- Epigenetics and single-cell genomics: epigenetic regulation, single-cell genomics and extracellular vesicles, addressing cellular heterogeneity and the layers of genomic control.表观遗传与单细胞基因组学： 表观遗传调控、单细胞基因组学与细胞外囊泡等新兴方向，关注细胞异质性与基因组调控层级的解析。
- Health and disease: genomic approaches to development, maintenance, ageing, human health and disease, spanning clinical genomics and precision medicine.健康与疾病研究： 以基因组学视角研究发育、维持、衰老、人类健康与疾病，涵盖临床基因组学与精准医学。
- Plant genomics: studies of plant genome structure and function fall within scope, while the journal states explicitly that it does not consider articles dealing with breeding and livestock.植物基因组学： 收录植物基因组结构与功能研究；官方明确不接收育种与畜禽类稿件。
The journal publishes research papers, full-length and mini-reviews, including proposals for hot-topic collections, as well as opinion pieces, and authors may propose collections themselves. Its 2025 impact factor stands at 4.0, placing it in zone four of biology in the Chinese Academy of Sciences ranking, with both biochemistry and molecular biology and genetics in the second quartile.刊物收录研究论文、长篇与简短综述（含热点专题提案）及观点文章，作者可主动提案组织热点专题。二〇二五年影响因子为四点〇，在中科院分区中列生物学四区，生化与分子生物学与遗传学两个小类均列二区。[1]
History
- Founding (2000): the journal was established in 2000 by Bentham Science Publishers under its present title, and remained with that publisher for more than two decades.创刊（二〇〇〇年）： 本刊于二〇〇〇年由本特纳姆科学出版社创办，创刊时刊名即为 Current Genomics，此后二十余年间一直由该社出版。[2]
- Contracting output (from 2023): after long running at eight issues a year, the journal reduced to six issues in 2023, five in 2024 and seven in 2025, a marked slowing of its publishing rhythm.刊量收缩（二〇二三年起）： 本刊历史上长期保持每年八期，二〇二三年减至六期，二〇二四年五期，二〇二五年七期，出刊节奏明显放缓。[3]
- Change of publisher (2026): from volume twenty-seven the journal moved to KeAi, and the international serial number authority now records the publisher as Elsevier on behalf of KeAi Communications出版方易主（二〇二六年）： 自第二十七卷起本刊改由 KeAi 出版，国际标准刊号权威记录将现行出版方登记为「爱思唯尔代表开科传播」；本特纳姆时期的第一至二十六卷仍由其平台存档。 volumes one to twenty-six from the Bentham era remain archived on its platform.[4]
- Move to full open access (2026): together with the change of publisher the journal moved from subscription to full open access, with an article processing charge of US$2,500 and discount and waiver schemes in place, having long been subscription-based.转向完全开放获取（二〇二六年）： 随出版方易主，本刊由订阅制转为完全开放获取，文章处理费为二千五百美元，提供折扣与豁免机制；此前长期为订阅制。[3]
- Metric trend: the impact factor rose to 4.0 in 2025, a clear recovery on earlier years, placing the title in the second quartile of both biochemistry and molecular biology and genetics.指标走势： 二〇二五年影响因子升至四点〇，较此前明显回升，进入生化与分子生物学与遗传学两个小类的二区。[5]
Editors
The editorial structure changed with the publisher. Under Bentham the journal was edited by Fabio Coppedè as editor-in-chief本刊编辑架构随出版方易主而更替。本特纳姆时期由法比奥·科佩德任主编，开科时期改为双主编制，两位共同主编分驻美国与意大利；编委会另设荣誉高级顾问、副主编与约四十人的编辑委员会。出版方未公布本刊录用比例与审稿时长。 under KeAi it runs a co-editor-in-chief arrangement, the two editors being based in the United States and Italy, supported by honorary senior advisors, associate editors and an editorial board of about forty members. The publisher publishes neither an acceptance rate nor a review duration for the title.[6]
- Amit Kumar Mitra and Fabio Virgili (co-editors-in-chief under KeAi): Mitra is based at the Harrison College of Pharmacy, Auburn University, in the United States, and Virgili at the National Inter-University Consortium for Bio-Structures and Bio-Systems in Italy阿米特·库马尔·米特拉与法比奥·维尔吉利（开科时期共同主编）： 米特拉供职于美国奥本大学哈里森药学院，维尔吉利供职于意大利国家生物结构与生物系统大学间联盟，二人共同主持现行编辑事务。 together they direct the journal's present editorial affairs.[6]
- Fabio Coppedè (editor-in-chief under Bentham): professor in the Department of Translational Research and of New Surgical and Medical Technologies at the University of Pisa, Italy, and editor-in-chief until the change of publisher.法比奥·科佩德（本特纳姆时期主编）： 任意大利比萨大学翻译研究与新型外科医学技术系教授，主编本刊至出版方易主。[7]
- Founding editor and honorary adviser: the founding editor was Stefan Pulst, while Christian Néri of the French National Institute of Health and Medical Research, a long-standing contributor to the journal's editorial work, now serves as honorary senior adviser.创刊编辑与荣誉顾问： 本刊创刊编辑为斯特凡·普尔斯特；法国国家卫生与医学研究院的克里斯蒂安·内里长期参与编务，现为荣誉高级顾问。[6]